Michael Seth Jensen

Dr. Michael Seth Jensen

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
CJCatherine Johnson
Catherine Johnson
MJMichael Seth Jensen
Michael Seth Jensen
JMJohn Musser
John Musser
NKNeil Kelkar
Neil Kelkar
KEKevin Eid
Kevin Eid
CCCraig J. Chaya
Craig J. Chaya
Background: In this study, we compare the 12-month results of eyes that underwent ab externo, open-conjunctival XEN45 gel stent placement with mitomycin C (MMC) with and without the intraoperative addition of Ologen collagen matrix (XEN45 and XEN45 + Ologen groups, respectively). Methods: Intraocular pressure (IOP) measurements were recorded postoperation at 1 month, 3 months, 6 months, and 9 months, and 12 months, and IOP reduction, reduction in number of IOP-lowering medications, and success rate were compared between XEN45 and XEN45 + Ologen groups. A complete success was defined as a ≥20% drop from baseline IOP at 12 months without the use of medications and without any of the following: an additional procedure (e.g., needling), a recorded IOP ≥ 21 mm Hg at two consecutive visits, or the occurrence of catastrophic events (e.g., no light perception (NLP)). A qualified success was defined as an IOP reduction of ≥20% from baseline with the use of medications. We included 145 eyes with at least 1 month of follow-up data, 46 in the XEN45 group and 99 in the XEN45 + Ologen group. Of these, 113 eyes had 12 months of follow-up data comprising 41 XEN45 eyes and 72 XEN45 + Ologen eyes. Results: There were no significant differences in the IOP change from baseline between XEN45 and XEN45 + Ologen groups except at the 3-month postop timepoint (p < 0.05). At the 12-month follow-up, 41.5% (17/41) of XEN45 eyes and 52.8% (38/72) of XEN45 + Ologen eyes met complete or qualified success criteria. Conclusions: No significant differences in success rate and decrease in the number of IOP-lowering medications from baseline were identified between XEN45 and XEN45 + Ologen groups.

1 February 2026 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
ASAllie Simpson
Allie Simpson
MHMarshall Henrie
Marshall Henrie
CWChaoRong Wu
ChaoRong Wu
BBBenjamin Brintz
Benjamin Brintz
SCStephen Christiansen
Stephen Christiansen
JWJudith Warner
Judith Warner
This study evaluated the effectiveness of surgeon self-reporting and anterior vitrector equipment billing in identifying intraoperative posterior capsular tears (PCT) with vitreous loss during cataract surgery. A total of 19,258 cataract surgeries performed over six years at the John A. Moran Eye Center were analyzed, with 343 potential complications identified through billing or self-reporting, and 193 confirmed PCT cases based on chart review. Billing data captured 83.9% of PCTs but lacked specificity, including many non-PCT uses of anterior vitrectomy. Surgeon self-reporting was highly specific, with 100% accuracy according to operative reports, but detected only 58.5% of total PCT cases. The findings highlight the strengths and limitations of both methods-billing is sensitive but overinclusive, while self-reporting is accurate but underutilized. Neither method alone was sufficient to identify all complications, emphasizing the need for a standardized, comprehensive approach to intraoperative complication monitoring to enhance patient safety and quality assurance in ophthalmic surgery.

3 November 2026 in Ophthalmology
Verified
Journal Article
Open access
MJMichael Seth Jensen
Michael Seth Jensen
ARAndy W. Renschler
Andy W. Renschler
CJCatherine Johnson
Catherine Johnson
CSCoy M. Steel
Coy M. Steel
DEDevin Eddington
Devin Eddington
BWBarbara M. Wirostko
Barbara M. Wirostko

30 September 2026 in Ophthalmology
Verified
Journal Article
Open access
MPMaria C. Pizarro Peñaranda
Maria C. Pizarro Peñaranda
AMAleksandra Mihailovic
Aleksandra Mihailovic
SCShashi Chaudhary
Shashi Chaudhary
NHNatalie Hamilton
Natalie Hamilton
YNYulia Nam
Yulia Nam
TJThomas Johnson
Thomas Johnson